Free Trial
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

iShares Biotechnology ETF logo
$128.56 -1.44 (-1.11%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iShares Biotechnology ETF (NASDAQ:IBB)

Key Stats

Today's Range
$128.28
$129.95
50-Day Range
$116.59
$130.02
52-Week Range
$107.43
$150.57
Volume
210,138 shs
Average Volume
1.46 million shs
Market Capitalization
$5.41 billion
Assets Under Management
$5.44 billion
Dividend Yield
0.30%
Net Expense Ratio
0.45%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.45%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.45%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.45%0.60%0.63%0.63%0.60%
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI
IBB: Now Is The Time To Be Contrarian
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

IBB ETF - Frequently Asked Questions

iShares Biotechnology ETF's stock was trading at $132.21 on January 1st, 2025. Since then, IBB stock has decreased by 1.7% and is now trading at $130.02.

Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017.The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

iShares Biotechnology ETF's top institutional shareholders include Neville Rodie & Shaw Inc. (0.10%) and Capital Market Strategies LLC (0.01%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
261

Fund Statistics

Assets Under Management
$5.44 billion
Average Daily Volume
$1.82 million
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
260
Put Options
61
Call Options
199
Short Interest
12,860,000 shs

Miscellaneous

Beta
0.73
Creation Unit
50,000
Creation Fee
$614.00
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure


This page (NASDAQ:IBB) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners